758 results on '"Chapman, Joab"'
Search Results
52. Immunoglobulin-Mediated Neuro-Cognitive Impairment: New Data and a Comprehensive Review
53. Narcolepsy, Infections, and Autoimmunity
54. Infections as a Cause of Guillain–Barré Syndrome
55. Contributors
56. Increased thrombin activity following reperfusion after ischemic stroke alters synaptic transmission in the hippocampus
57. Human antiphospholipid antibodies induce TNFα in monocytes via Toll-like receptor 8
58. The combined treatment of Copaxone and Salirasib attenuates experimental autoimmune encephalomyelitis (EAE) in mice
59. Experimental Automimmune Dementia (EAD): An Immunological Model of Memory Dysfunction and Alzheimer’s Disease
60. Mice with experimental antiphospholipid syndrome display hippocampal dysfunction and a reduction of dendritic complexity in hippocampal CA1 neurones
61. TLR7 and TLR8 ligands and antiphospholipid antibodies show synergistic effects on the induction of IL-1β and caspase-1 in monocytes and dendritic cells
62. Systemic inflammation is associated with a reduction in Synaptopodin expression in the mouse hippocampus
63. Superior temporal gyrus thickness correlates with cognitive performance in multiple sclerosis
64. Treatment for experimental autoimmune neuritis with clodronate (Bonefos)
65. Ischemic stroke in PAR1 KO mice: Decreased brain plasmin and thrombin activity along with decreased infarct volume
66. Guillain–Barré Syndrome—A Classical Autoimmune Disease Triggered by Infection or Vaccination
67. The Strategies Used for Treatment of Experimental Autoimmune Neuritis (EAN): A Beneficial Effect of Glatiramer Acetate Administered Intraperitoneally
68. Immunology, Autoimmunity, and Autoantibodies in Parkinson’s Disease
69. The EEG in E200K familial CJD: relation to MRI patterns
70. Is C-reactive protein level a marker of advanced motor and neuropsychiatric complications in Parkinson’s disease?
71. Tau and 14-3-3 of genetic and sporadic Creutzfeldt–Jakob disease patients in Israel
72. Pruritus in familial Creutzfeldt–Jakob disease: a common symptom associated with central nervous system pathology
73. Sarcoidosis Presenting as “Corset-like” Myelopathy: A Description of Six Cases and Literature Review
74. The Pathogenesis of Neural Injury in Animal Models of the Antiphospholipid Syndrome
75. Web-based Multi-center Data Management System for Clinical Neuroscience Research
76. Steroid-responsive, progressive, focal measles virus brain infection
77. MRI Detection of the Cerebellar Syndrome in Creutzfeldt–Jakob Disease
78. Neuromylelitis Optica (Devic Syndrome)
79. Autoantibodies to Annexin A2 and cerebral thrombosis: Insights from a mouse model
80. Early Fluid Attenuation Inversion Recovery Sulcal Contrast Enhancement Correlates with Severity of Reversible Cerebral Vasoconstriction Syndrome
81. Markers for neural degeneration and regeneration: novel highly sensitive methods for the measurement of thrombin and activated protein C in human cerebrospinal fluid
82. Coagulation in Inflammatory Diseases of the Central Nervous System
83. Increased brain plasmin levels following experimental ischemic stroke in male mice
84. Calpastatin levels affect calpain activation and calpain proteolytic activity in APP transgenic mouse model of Alzheimer's disease
85. Treatment of Diabetic Neuropathy with A Novel PAR1-Targeting Molecule
86. In-thrombus thrombin secretion: a new diagnostic marker of atrial fibrillation in cryptogenic stroke
87. Early Fluid Attenuation Inversion Recovery Sulcal Contrast Enhancement Correlates with Severity of Reversible Cerebral Vasoconstriction Syndrome
88. The imaging appearance of Creutzfeldt–Jakob disease caused by the E200K mutation
89. Rectracted: Anti-ribosomal-phosphoprotein autoantibodies penetrate to neuronal cells via neuronal growth associated protein, affecting neuronal cells in vitro.
90. Anatomical localization of protease-activated receptor-1 and protease-mediated neuroglilal crosstalk on peri-synaptic astrocytic endfeet
91. Brain Protease Activated Receptor 1 Pathway: A Therapeutic Target in the Superoxide Dismutase 1 (SOD1) Mouse Model of Amyotrophic Lateral Sclerosis
92. Glatiramer Acetate Depot (extended-release) phase IIa study in patients with relapsing remitting multiple sclerosis: safety, tolerability and efficacy (No Evidence of Disease Activity) subpopulation three-years analysis (1936)
93. A Novel Highly Sensitive Method for Measuring Inflammatory Neural-Derived APC Activity in Glial Cell Lines, Mouse Brain and Human CSF
94. Central and Peripheral Mechanisms in ApoE4-Driven Diabetic Pathology
95. The association of quantitative EEG and MRI in Creutzfeldt‐Jakob Disease
96. Abnormal olfactory function demonstrated by manganese-enhanced MRI in mice with experimental neuropsychiatric lupus
97. Ancestral origins and worldwide distribution of the PRNP 200K mutation causing familial Creutzfeldt-Jakob disease
98. Thalamo-striatal diffusion reductions precede disease onset in prion mutation carriers
99. Hyperactivity Induced by Antiphospholipid Syndrome Serum
100. Gluten Sensitivity in Multiple Sclerosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.